Teva Pharmaceutical Industries Limited (NYSE: TEVA) is a large market cap stock with a market cap of 52758.85. It is in the Drug Manufacturers – Other industry and sector Healthcare, with a current P/E of 34.41, a forward P/E of 8.68 and EPS of 1.5. At a stock price of 51.55 (0.68%) it has a dividend yield of 2.64%.
EPS growth for the last five years have been -13.10%, more recently this last year it has grown by -48.90%. The next year growth is going to be about 12.84% and more long-term 5.20% after five years. EPS growth quarter over quarter is -67.40%. Sales growth for the past five years have been 4.00% and sales growth quarter over quarter is 1.40%.
For performance, Teva Pharmaceutical Industries Limited the past week has seen a gain of -2.72%. For the last month performance for Teva Pharmaceutical Industries Limited is -5.31%. While the last quarter is 0.43% and half year, -6.06%. Finally for the year, performance is -18.94%.
The 52-week high for Teva Pharmaceutical Industries Limited, is at -21.05%, and for the 52-week low it comes to a value of 8.07%. The 20-day simple moving average is -1.61% and -7.97% for the 200-day simple moving average.
Volatility for the week is at 2.97%, and for the month it is 2.36%. Teva Pharmaceutical Industries Limited, has a target price of 69.59.
In terms of debt, long term debt/equity is 0.27, and for total debt/equity Teva Pharmaceutical Industries Limited has 0.36. The gross margin is 57.70%, while operating margin is 17.70%, the profit margin is 6.90%. The current ratio is 1.3 and the quick ratio is 1.
Insider ownership is at 2.70%, with instituitional ownership at 59.20%. Teva Pharmaceutical Industries Limited has a payout ratio of 67.50%. With the total shares outstanding coming to 1023.45. The shares float is 1014.36, with the float short at 1.36%, with short ratio coming to 2.4.
In terms of returns, the return on assets see Teva Pharmaceutical Industries Limited, get 2.50%, with its returns on investment at 5.70%. Return on equity is 4.90%. So will the investors see the target price of 69.59, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.